Yulia Frangulova, LINLINE Medical Systems - Medical Laser Design & Production | LSI USA '24

Yulia Frangulova  0:03  
I'm Yulia Frangulova, co founder of linline medical systems, and thanks to LSI for the opportunity to present linline medical system is the producer of medical lasers. Our flagship product is the multifunctional platform, which is equipped with several laser amateurs at the same time and has more than 50 applications, in surgery, in oscetic medicine, in dermatology. Our latest innovation, which is realized in this multifunctional platform, is recoursema, which is tissue regeneration and wound healing technology actually requires, my is a great solution for the problems people have concerned since ancient times. So how to stay forever young, how to erase the scars, how to heal wounds. Now, the recourse, ma and it's not the idea. It's real product, which is already on the market, is successfully applied in esthetic medicine, for treatment of scarcer in rejuvenating treatments, and actually it's a good replacement for fillers, which are now not as popular as even five years ago. But the most important application nowadays is treatment of non healing wounds, which seems more important as well for development of this product and for profitable investment. How does it work? This is a revolutionary technology which triggers the hidden mechanism of reparative tissue regeneration and starts the biological process where the body restores damage to lost tissues to the original state. Here is some video, just to have you the imagination, how the laser works. So it's counter class treatment of non healing wound, and you can see here non healing wound, which has been treated several times. It's absolutely painless, and Anastasia doesn't need it. So these are the results for diabetic food, trophic ulcers, for different types of foods, and also for esthetic medicine, it's also painless in comparison with other similar treatments, and has absolutely different result due to the ability of this new technology to replace pathological tissue with the New healthy ones. So recosma refers our body to information which is in our DNA and restore the tissues without any signs of disease and signs of aging. So here are also some clinical examples of rejuvenation and the treatment of scars. And I think that for majority of you, topic of rejuvenation and scar removal, maybe seems much more interesting, but we have 100% sure assurance that it's more important the implicate the application of this technology in wound healing. Let's have a look at this frostbite. This tourist was caught in avalanche in Himalayas, and doctors told him that there was no other way but amputation. And fortunately, he was recommended three Cosmo treatment, and after 12 session, he got full recovery. Actually, his one complaint was that fingers become more sensitive due to the new ending, new nerve ending growth. Other example of non healing burn, this patient watered the hospital for two months with no dynamic and only two session of recourse. One was done and the restoration of the skin you can see on the last picture. Here is the example of treatment of diabetic foot ulcer, which is the most maybe dangerous condition of health and the most dangerous type of wound in two months, patient got almost full recovery. This technology is also very effective in wound healing and applicable for wounds regardless of whether it's gun short wound or chemical burn. And recently, we donated one of our laser to military hospital in Ukraine, and now there are doctors there successfully treat soldiers and also, unfortunately, civil victims of this war. Why do we believe that among all the application, which, as I stated, more than 15 dermatology, ascetic medicine in surgery had to heal wounds, is the main thing we should focus on, actually, for nowadays, conventional treatments. Of chronic wounds are costly and ineffective, and we are 100% sure that our technology, very soon, will be the gold standard in wound care industry. Have a look how many people suffer from different types of chronic wounds, only in us, so about 8 million people and recosma can actually help almost everybody, of them, but the diabetic foot ulcers is there, as I've already told, the most dangerous state. And we try to focus on development of this direction of our activity. Why? Because every 30 seconds in the world, a patient with diabetes requires an amputation. 70% of fall amputation are caused by diabetic foot ulcers. More than half will get infected, and unfortunately, around 70% it's world statistic of amputated diabetic foot ulcer patients will die within five years, estimated expenditures only in us for treatment of diabetic food ulcer is around 15 billion. Here is also the statistic for US and the UK. How much is spended for different type of very serious disease. And you can see that diabetic food treatment is at first place, and unfortunately, it costs much more, and it has higher mortality rate than even breast cancer or colon cancer. And let's imagine the scale of the problem worldwide. So it's a huge potential market, actually, what was done for today. So we already got CE mark. The product is on the market in Europe, in some Asian countries. We get in a few countries, patents, and now the aim to raise around 10 million for getting start FDA approval and RCT studies to get reimbursement courts and to expand our production and improve marketing activity. Here is our core team, not all the professionals we work with and join us to transform wound care industry into wound pure ones. Thank you for your attention, and welcome to innovator Pavley on table 50. We've got some changes actually, so thank you very much. Applause.